Curriculum vitae
of Curtis L. Atkin

October 11, 1999


I. EDUCATION AND DEGREES:
9/48-6/59.  Cedar City, Utah, schools.
9/58-6/59.  Southern Utah State College, Cedar City, math.
9/59-6/62.  Brigham Young University, Provo, Utah, chemistry.
9/62-6/64.  B.S. in chemistry, California Institute of Technology, Pasadena.
9/65-6/70.  Ph.D. in biochemistry, University of California at Berkeley.
1/71-12/72. Stockholms Universitet, Swedish.

IIa. PROFESSIONAL EXPERIENCE - POSITIONS:

6-9/62. Research assistant in thermochemistry with Dr. R. M. Izatt, Department of Chemistry, Brigham Young University, Provo, Utah.

6-9/63. Undergraduate research fellow in electroanalytical chemistry, with Dr. F. C. Anson, Department of Chemistry, California Institute of Technology, Pasadena.

6-9/64. Chemist at North American Aviation Science Center, Thousand Oaks, California.

9-12/65. Teaching assistant, Department of Biochemistry, University of California at Berkeley.

4/70-3/73. Postdoctoral fellow with Dr. P. Reichard, Chemistry Department 2 and Medical-Nobel Institute, Karolinska Institutet, Stockholm, Sweden.

4/73-11/85. Research Assistant Professor, Hematology-Oncology Division, Department of Medicine, University of Utah.

4/73-6/89. Research Assistant Professor, Department of Biochemistry, University of Utah.

3-4/79. Consultant for Motion Control Inc., Salt Lake City. Iontophoreses of steroids.

1/83-12/84. Leave of absence for health reasons.

11/85-6/88. Research Assistant Professor, Rheumatology Division, Department of Medicine, University of Utah.

7/88- . Research Associate Professor, Rheumatology Division, Department of Medicine, University of Utah.

7/89- . Research Associate Professor, Department of Biochemistry, University of Utah.

1/94. Retirement on disability.

1/94- . Occasional consultant, interdepartmental Alport Syndrome Study, and Rheumatology Div., University of Utah.

7/99. Consultant, Kendall Strategies Inc.

IIb. PROFESSIONAL EXPERIENCE - JOURNAL REVIEWER:
American Journal of Medical Genetics
American Journal of Pathology
Archives of Biochemistry and Biophysics
Clinical Chemistry
Journal of Biological Chemistry
Science

IIc. PROFESSIONAL EXPERIENCE - SCHOLARSHIP AND RESEARCH AWARDS:

1961. Texaco scholarship in chemistry.

1962. Kennecott scholarship in chemistry.

6-9/63. National Science Foundation (NSF) undergraduate summer research fellowship.

9/64-8/68. NSF individual graduate fellowship.

8/69-1/70. Postdoctoral fellowship awards from National Institutes of Health (NIH), American Cancer Society, and Leonard Wood Memorial Foundation, declined in favor of the next item.

4/70-3/73. Postdoctoral fellowship, Helen Hay Whitney Foundation.

11/71. Short-term special study fellowship, the European Molecular Biology Organization.

10/74-12/94. Principal Investigator, Clinical Research Center protocol 73-19, "Hereditary Nephritis Study," NIH MO1 RR00064.

3/79-12/94. Principal Investigator, research grants from the Hereditary Nephritis Foundation.

7/79-6/81. NIH grant AM 25600, "Leukocyte Myeloperoxidase Family Studies," consultant then co-Principal Investigator (with Dr. H. Eyre).

4/79-3/81. Principal Investigator, March of Dimes Birth Defects Foundation grant 6-213, "Biochemical Characterization and Immunological Localization in Kidney of Abnormal Urine Protein in Hereditary Nephritis."

1/80-12/82. Principal Investigator, NIH grant R01 AM 26627, "Molecular Pathogenesis of Hereditary Nephritis."

4/87-3/90. Coinvestigator, NIH grant 5R01 AM (dual CA) 12103, "Mycoplasma Cell Interactions," principal investigator B. C. Cole.

3/88-2/93. Principal Investigator, NIH grant 1R01 DK 39497, "Genetic Characterization of Alport Syndrome."

4/89-3/94. Coinvestigator, NIH grant R01 AR 02255, "The Mycoplasma arthritidis T-Cell Mitogen," principal investigator B. C. Cole.

IId. PROFESSIONAL EXPERIENCE - INTERESTS:
Structure and function of metalloproteins.
Genetics and biochemistry of hereditary diseases.
Interactions of superantigens with components of the immune system.

III. HONORS:
Phi Eta Sigma.
Phi Kappa Phi.
BYU honors program.
"Outstanding beginning chemistry student," BYU, 1961.
"Outstanding organic chemistry student," BYU, 1962.
Two University of Utah Inventors Incentive Awards.

IV. PROFESSIONAL COMMUNITY ACTIVITIES:

1978-81. March of Dimes, Salt Lake City chapter, Board.

1978-96. Founder and Board Member, The Hereditary Nephritis Foundation (HNF).

1980. Social Committee, American Chemical Society Rocky Mountain Regional Conference.

1989-91. National Kidney Foundation of Utah, Board and Executive Committee.

1991. NIDDK Planning Committee, "Role of Genetics in Renal Diseases."

1992-4. Alport Syndrome Consortium, Steering Committee.

1998-9. Planning Committee, Fourth International Workshop on Alport Syndrome.

V. PUBLICATIONS:

  1. HB Mark Jr, CL Atkin. Electrode reactions of aromatic compounds in strong acid solutions. Chronopotentiometric and spectrometric studies of the p-hydroquinone-H2SO4 system at platinum electrodes. Analytical Chemistry 36:514-520, 1964.

  2. CL Atkin, EP Parry, DH Hern. Chromatographic separation of tertiary nitrogen compounds from photodynamic dye precursors. Analytical Chemistry 39:672-673, 1967.

  3. CL Atkin, JB Neilands. Rhodotorulic acid, a diketopiperazine dihydroxamic acid with growth-factor activity. I. Isolation and characterization. Biochemistry 7:3734-3739, 1968.

  4. CL Atkin. Rhodotorulic Acid. Doctoral thesis, June, 1970, Department of Biochemistry, University of California, Berkeley 94720, 148 pages. Order no. 71-9756, University Microfilms, Ann Arbor, Michigan. Summary in Dissertation Abstracts International 31, 5784-B, 1971.

  5. CL Atkin, JB Neilands, HJ Phaff. Rhodotorulic acid from species of Leucosporidium, Rhodosporidium, Rhodotorula, Sporidiobolus, and Sporobolomyces, and a new alanine-containing ferrichrome from Cryptococcus melibiosum. Journal of Bacteriology 103:722-733, 1970.

  6. CL Atkin, JB Neilands. Leaf infections: siderochromes (natural polyhydroxamates) mimic the "green island" effect. Science 176:300-302, 1972.

  7. C Atkin, A Ehrenberg, G Lang, C Moleski, T Moss, P Reichard, L Thelander. Protein B2 of ribonucleotide reductase. Biophysical properties of a new type of iron containing protein. Pages 569-582 in GM Frank & LP Kayushin editors, Symposial Papers of the International Biophysics Congress 4th 2(2). Akademi Nauk SSSR, Pushchino-on Oka, USSR 1972 (Pub. 1973).

  8. CL Atkin, L Thelander, P Reichard, G Lang. Iron and free radical in ribonucleotide reductase. Exchange of iron and Mössbauer spectroscopy of the protein B2 subunit of the Escherichia coli enzyme. Journal of Biological Chemistry 248:7464-7472, 1973.

  9. HA Akers, CL Atkin, JB Neilands. Mass spectroscopy of hydroxamic acids: fragmentation by the loss of the hydroxylamino oxygen. Organic Mass Spectrometry 10:259-262, 1975.

  10. DM Williams, CL Atkin, DB Frens, PF Bray. Menkes' kinky hair syndrome: studies of copper metabolism and long-term copper therapy. Pediatric Research 11:823-826, 1977.

  11. DM Williams, AJ Barbuto, CL Atkin, GR Lee. Mitochondrial iron uptake and heme synthesis in copper deficiency. Pages 341-347 in EB Brown editor, Proteins of Iron Metabolism, Grune & Stratton, New York, 1977.

  12. CL Atkin, RL Stephen. Leakage indicator for recirculating peritoneal dialysis. U.S. Patent No. 4081372, Official Gazette of the U.S. Patent and Trademark Office, March 28, 1978. (To Baxter-Travenol Labs.).

  13. WM O'Neill Jr, CL Atkin, HA Bloomer. Hereditary nephritis: a re-examination of its clinical and genetic features. Annals of Internal Medicine 88:176-182, 1978.

  14. DM Williams, AJ Barbuto, CL Atkin, GR Lee. Evidence for an iron carrier substance in copper-deficient mitochondria. Pages 539-545 in GJ Brewer editor, Progress in Clinical and Biological Research, Vol 21, The Red Cell, Liss, New York, 1978.

  15. DM Williams, CL Atkin, AR Seay, PF Bray. Failure of human milk therapy in Menkes' kinky hair disease. American Journal of Diseases of Children 133:218-219, 1979.

  16. WM O'Neill Jr, RP Mennemeyer, HA Bloomer, CL Atkin. Early pathologic features of hereditary nephritis: a clinicopathologic correlation. Pathology Research and Practice 168:146-162, 1980.

  17. RL Stephen, C Kablitz, D van Dura, CL Atkin, SC Jacobsen. Iodine composition and method for prevention and treatment of dialysis induced peritonitis. U.S. Patent No. 4235230. Official Gazette of the U.S. Patent Office, November 25, 1980.

  18. DM Williams, CL Atkin. Tissue copper concentrations of patients with Menkes' kinky hair disease. American Journal of Diseases of Children 135:375-376, 1981.

  19. M Kitahara, HJ Eyre, Y Simonian, CL Atkin, SJ Hasstedt. Hereditary myeloperoxidase deficiency. Blood 57:888-893, 1981.

  20. MR Andersen, CL Atkin, HJ Eyre. Intact form of myeloperoxidase from normal human neutrophils. Archives of Biochemistry and Biophysics 214:273-283, 1982.

  21. CL Atkin, MR Andersen, HJ Eyre. Abnormal neutrophil myeloperoxidase from a patient with chronic myelocytic leukemia. Archives of Biochemistry and Biophysics 214:284-292, 1982.

  22. FJ Chiu, CL Atkin. Catabolites of the third component of complement in urines of hereditary nephritis patients. Journal of Biological Chemistry 258:7200-7207, 1983.

  23. SJ Hasstedt, CL Atkin. X-Linked inheritance of Alport syndrome: family P revisited. American Journal of Human Genetics 35:1241-1251, 1983.

  24. DL Smith, C Atkin, C Westenfelder. Stable isotopes of calcium as tracers: methodology. Clinica Chimica Acta 146:97-101, 1985.

  25. KB Nielson, CL Atkin, DR Winge. Distinct metal-binding configurations in metallothionein. Journal of Biological Chemistry 260:5342-5250, 1985.

  26. FJ Chiu, CL Atkin. Polypeptide fragments of the third component of complement in urine of hereditary nephritis patients. Journal of Immunology 134:4057-4061, 1985.

  27. SJ Hasstedt, CL Atkin, AC San Juan Jr. Genetic heterogeneity among kindreds with Alport syndrome. American Journal of Human Genetics 38:940-953, 1986.

  28. CL Atkin, BC Cole, GJ Sullivan, LR Washburn, and BB Wiley. Stimulation of mouse lymphocytes by a mitogen derived from Mycoplasma arthritidis . V. A small basic protein from culture supernatants is a potent T-cell mitogen. Journal of Immunology 137:1581-1589, 1986.

  29. CL Atkin, MC Gregory, WA Border. Alport syndrome. Chapter 19 (pages 617-641) in RW Schrier & CW Gottschalk editors, Diseases of the Kidney, Fourth Edition, Little, Brown & Co., Boston, 1988.

  30. CL Atkin, SJ Hasstedt, L Menlove, L Cannon, N Kirschner, C Schwartz, K Nguyen, M Skolnick. Mapping of Alport syndrome to the long arm of the X chromosome. American Journal of Human Genetics 42:249-255, 1988.

  31. MC Gregory, WA Border, CL Atkin. Hereditary nephropathies. Chapter 118 (pages 791-793) in WN Kelley editor, Textbook of Internal Medicine, Lippincott, Philadelphia, 1989.

  32. CE Kashtan, CL Atkin, MC Gregory, AF Michael. Identification of variant Alport phenotypes using an Alport-specific antibody probe. Kidney International 36:669-674, 1989.

  33. DF Barker, SL Hostikka, J Zhou, LT Chow, AR Oliphant, SC Gerken, MC Gregory, MH Skolnick, CL Atkin, K Tryggvason. Identification of mutations in the COL4A5 collagen gene in Alport syndrome. Science 248:1224-1227, 1990.

  34. J Zhou, DF Barker, SL Hostikka, MC Gregory, CL Atkin, K Tryggvason. Single base mutation in 5(IV) collagen chain gene converting a conserved cysteine to serine in Alport syndrome. Genomics 9: 10-18, 1991.

  35. BC Cole, CL Atkin. The Mycoplasma arthritidis T cell mitogen, MAM: a model superantigen. Immunology Today 12 (8):271-276, 1991.

  36. DF Barker, PR Fain, DE Goldgar, JN Dietz-Band, AE Turco, CE Kashtan, MC Gregory, K Tryggvason, MH Skolnick, CL Atkin. High-density genetic and physical mapping of DNA markers near the X-linked Alport syndrome locus: definition and use of flanking polymorphic markers. Human Genetics 88:189-194, 1991.

  37. MC Gregory, CL Atkin. Hereditary nephropathies. Chapter 118 (pages 736-738)) in WN Kelley editor, Textbook of Internal Medicine, 2nd edition, Lippincott, Philadelphia, 1992.

  38. MC Gregory, CL Atkin. Alport syndrome, Chapter 19 (pages 571-591) in RW Schrier & CW Gottschalk editors, Diseases of the Kidney, Fifth Edition, Little, Brown & Co., Boston, pages 571-591, 1993.

  39. J Zhou, MC Gregory, JM Hertz, DF Barker, C Atkin, ES Spencer, K Tryggvason. Mutations in the codon for a conserved arginine-1563 in the COL4A5 gene in Alport syndrome. Kidney International 43:722-729, March 1993.

  40. BC Cole, E Ahmed, BA Araneo, J Shelby, C Kamerath, S Wei, S McCall, CL Atkin. Immunomodulation in vivo by the Mycoplasma arthritidis superantigen, MAM. Clinical Infectious Diseases 17(Suppl 1):S163-9, August 1993.

  41. CL Atkin, S Wei, BC Cole. The Mycoplasma arthritidis superantigen MAM: Purification and identification of an active peptide. Infection and Immunity, 62(12):5367-5375, December 1994.

  42. DC Wester, CL Atkin, MC Gregory. Alport syndrome: clinical update. Journal of the American Academy of Audiology 6(1):73-79, January 1995.

  43. T Sawada, R Pergolizzi, K Ito, J Silver, C Atkin, BC Cole, MDY Chang. Replacement of the DR alpha chain with the E alpha chain enhances presentation of Mycoplasma arthritidis superantigen by the human Class II DR molecule. Infection and Immunity 63(9):3367-3372, September 1995.

  44. BC Cole, CL Atkin. Identification, characterization and purification of mycoplasmal superantigens. Chapter F6 (pages 439-449) in Molecular and Diagnostic Procedures in Mycoplasmology, Volume I, Molecular Characterization, S Razin and JG Tully, eds. Academic Press, San Diego, 1995. NLM Call No. QW 143 M718 1995, ISBN 0-12-583805-0.

  45. BC Cole, KL Knudtson, A Oliphant, AD Sawitski, A Pole, M Manohar, LS Benson, E Ahmed, CL Atkin. The sequence of the Mycoplasma arthritidis superantigen, MAM: identification of functional domains and comparison with microbial superantigens and plant lectin mitogens. Journal of Experimental Medicine 183(3):1105-1110, 1 March 1996.

  46. MC Gregory, DA Terreros, DF Barker, PR Fain, JC Denison, CL Atkin. Alport syndrome -- clinical phenotypes, incidence, and pathology. Pages 1-28 in: K Tryggvason editor, Molecular Pathology and Genetics of Alport Syndrome. Contributions to Nephrology (Contrib. Nephrol. Basel), Volume 117, S. Karger AG, Basel, 1996. NLM Call No. WJ 353 M718 1996.

  47. DF Barker, CL Atkin, MC Gregory, PR Fain. Application of linked markers for genetic diagnosis of Alport syndrome. Pages 29-45 in: K Tryggvason editor, Molecular Pathology and Genetics of Alport Syndrome. Contributions to Nephrology (Contrib. Nephrol. Basel), Volume 117, S. Karger AG, Basel, 1996. NLM Call No. WJ 353 M718 1996.

  48. N Heiskari, X Zhang, J Zhou, A Leinonen, D Barker, M Gregory, CL Atkin, KO Netzer, M Weber, S Reeders, C Grönhagen-Riska, HPH Neumann, R Trembath, K Tryggvason. Identification of 17 mutations in ten exons in the COL4A5 collagen gene, but no mutations found in four exons in COL4A6 : a study of 250 patients with hematuria and suspected of having Alport syndrome. Journal of the American Society of Nephrology 7(5):702-709, May 1996.

  49. DF Barker, CJ Pruchno, X Jiang, CL Atkin, EM Stone, JC Denison, PR Fain, MC Gregory. A mutation causing Alport syndrome with tardive hearing loss is common in the western United States. American Journal of Human Genetics 58(6):1157-1165, June 1996.

  50. MC Gregory, CL Atkin. Alport's Syndrome, Fabry's Disease, and Nail-Patella Syndrome, Chapter 19 (pages 561-590) in RW Schrier & CW Gottschalk editors, Diseases of the Kidney, Sixth Edition, Lippincott Williams & Wilkins Publishers, 1996. NLM Call No.WJ 300 D611 1996, ISBN 0-316-77456-1.

  51. MC Gregory, CL Atkin. Hereditary nephropathies, Chapter 157 (pages 1018-1020) in WN Kelley editor, Textbook of Internal Medicine, 3rd edition, Lippincott, Philadelphia, 1997. NLM Call No. WB 115 T355 1997.

  52. DF Barker, JC Denison, CL Atkin, MC Gregory. Common ancestry of three Ashkenazi-American families with Alport Syndrome and COL4A5 R1677Q. Human Genetics 99:681-684, May 1997. The abstract may be seen online and the entire paper downloaded in pdf format.

  53. BC Cole, CL Atkin, AR Oliphant, A Pole. Mycoplasma arthritidis T-cell mitogen. U.S. Patent No. 5639869, Official Gazette of the U.S. Patent and Trademark Office, June 17, 1997.

  54. BC Cole, AD Sawitzke, EA Ahmed, CL Atkin, CS David. Allelic polymorphisms at H-2A and HLA-DQ loci influence the response of murine lymphocytes to the Mycoplasma arthritidis superantigen MAM. Infection and Immunity 65(10):4190-4198, October 1997.

  55. BC Cole, CL Atkin, KL Knudtson. Mycoplasma arthritidis superantigen. U.S. Patent No. 5795974, Official Gazette of the U.S. Patent and Trademark Office, August 18, 1998.

  56. S Sasaki, B Zhou, WW Fan, Y Kim, DF Barker, JC Denison, CL Atkin, MC Gregory, J Zhou, Y Segal, Y Sado, Y Ninomiya, AF Michael, CE Kashtan. Expression of mRNA for type IV collagen 1, 5 and 6 chains by cultured dermal fibroblasts from patients with X-linked Alport syndrome. Matrix Biology 17(4):279-291, August 1998.

  57. P Martin, N Heiskari, J Zhou, A Leinonen, T Tumelius, JM Hertz, D Barker, M Gregory, C Atkin, U Styrkarsdottir, H Neumann, J Springate, T Shows, E Pettersson, K Tryggvason. High mutation detection rate in the COL4A5 collagen gene in suspected Alport syndrome using PCR and direct DNA sequencing. Journal of the American Society of Nephrology 9(12):2291-2301, December 1998.

  58. BC Cole, CL Atkin et al. Mycoplasma arthritidis T-Cell Mitogen U.S. Patent No. 5872233, Official Gazette of the U.S. Patent and Trademark Office, February 16, 1999.

VI. PUBLISHED LETTERS OF COMMENT:

  1. WM O'Neill Jr, CL Atkin. Letters. Annals of Internal Medicine 89:286, 1978. Comments on adjacent letters by others regarding our paper WM O'Neill Jr, CL Atkin, HA Bloomer. Hereditary nephritis: a re-examination of its clinical and genetic features. Annals of Internal Medicine 88:176-182, 1978.

  2. MC Gregory, CL Atkins [sic], DF Barker. Hearing loss. New England Journal of Medicine 330(10):714-715, 1994. Comments on JB Nadol Jr. Hearing loss. New England Journal of Medicine 329(15):1092-1102, March 1993.

VII. ABSTRACTS AND CONFERENCE PRESENTATIONS:
(* indicates presentation by CL Atkin)

  1. * CL Atkin, JB Neilands. Isolation and characterization of a new sideramine from a yeast species. Pacific Slope Biochemical Conference, Abstracts, 73, June 15-17, 1967.

  2. JA Salas, CL Atkin. Preliminary characterization of a Penicillium metabolite which induces the perfect stage of Mycena citricolor. Phytopathology 60, 1541-1542, 1970.

  3. CL Atkin. Structure and function of the iron in ribonucleoside diphosphate reductase from Escherichia coli. Fourteenth Annual Meeting of the Research Fellows, Helen Hay Whitney Foundation, Summary Reports, 5-9, Glen Cove, New York, December 20, 1971.

  4. A Ehrenberg, C Atkin, G Lang, C Molesku, T Moss, P Reichard, L Thelander. Protein B2 of ribonucleotide reductase. Biophysical properties of a new type of iron containing protein. Abstracts, 61, no. SV-3/2. International Union of Pure and Applied Biophysics, 4th International Biophysics Congress, Moscow, August 7-14, 1972.

  5. * CL Atkin. The iron center of E. coli ribonucleoside diphosphate reductase. Second Linderstrøm-Lang Conference, Hindås, Sweden, August 28-September 1, 1972.

  6. * CL Atkin. Ribonucleotide reductase. Fifteenth Annual Meeting of the Research Fellows, Helen Hay Whitney Foundation, Summary Reports, 56-57, Glen Cove, New York, November 17-19, 1972.

  7. RL Stephen, GC Leroy, A Maldonado, C Atkin, D van Dura, WJ Kolff. Recirculating peritoneal dialysis with a subcutaneous peritoneal catheter. Eighth Annual Meeting of the American Society of Nephrology, Abstracts, 39, Washington, DC, November 25-26, 1975.

  8. WM O'Neill, CL Atkin, HA Bloomer. Correlation of clinical and genetic information in hereditary nephritis. Ninth Annual Meeting aof the American Society of Nephrology. Abstracts, 21, Washington, DC, November 21-23, 1976.

  9. DM Williams, AJ Barbuto, CL Atkin, GR Lee. Studies of an iron-containing substance in copper deficient mitochondria. Clinical Research 26, 22A, 1978.

  10. FD Hileman, CL Atkin, GR Lee, DL Smith, BM Hughes. The use of stable isotopes in determining the kinetics of copper metabolism in animals. Proceeding of the Twenty-sixth Annual Conference on Mass Spectrometry and Allied Topics, 336-338, St Louis, Missouri, May 28-June 2, 1978.

  11. * CL Atkin, WM O'Neill Jr, TR Lloyd, HA Bloomer. A unique urinary protein in Alport's syndrome. Eleventh Annual Meeting of the American Society of Nephrology, Abstracts, 102A, New Orleans, November 19-21, 1978.

  12. DP Duffy, CL Atkin, JT Wu, HA Bloomer. Beta 2 microglobulinuria in hereditary nephritis. Clinical Research 28, 62A, 1980.

  13. TR Lloyd, CL Atkin, WM O'Neill Jr, HA Bloomer. The urine protein specific to hereditary nephritis is a breakdown product of complement component C3. Clinical Research 28, 63A, 1980.

  14. CL Atkin, MR Andersen, HJ Eyre. Structure of human neutrophil myeloperoxidase. Clinical Research 29, 329A, 1981.

  15. E Palomaki, DE Jeffery, CL Atkin. Karyotypic investigations of Alport syndrome. Encyclia 58, 160, 1981.

  16. * CL Atkin. Alport syndrome. Dean's Research Conference, Snowbird, Utah, October, 1983.

  17. DL Smith, CL Atkin, RL Baranowski, C Westenfelder. Mass spectrometry of stable calcium isotopes, a new method for the study of mineral metabolism in humans. Clinical Research 32, 408A, 1984.

  18. L Menlove, J Aldridge, C Schwartz, C Atkin, S Hasstedt, L Kunkel, G Bruns, S Latt, M Skolnick. Linkage between Alport syndrome-like hereditary nephritis and X-linked RFLPS. American Journal of Human Genetics 36, 146S, 1984.

  19. L Menlove, N Kirschner, K Nguyen, T Morrison, J Aldridge, C Schwartz, C Atkin, S Hasstedt, L Kunkel, G Bruns, S Latt, M Skolnick. Linkage between Alport syndrome-like hereditary nephritides and X-linked RFLPs. Human Gene Mapping 8, Cytogenetics and Cell Genetics 40, 697-698, 1985.

  20. * CL Atkin, BC Cole, SJ Sullivan. Extracellular T-cell mitogen from Mycoplasma arthritidis. Sixth International Congress of the International Organization for Mycoplasmology (IOM), Birmingham, Alabama, August 26-31, 1986. Israel Journal of Medical Sciences 23(5):515, 1987.

  21. J Dietz-Band, A Turco, H Willard, D Goldgar, J-L Mandel, C Atkin, M Skolnick, D Barker. Characterization and physical localization of 37 RFLPs for the X chromosome and linkage of two markers to the gene for X-linked Alport syndrome. American Journal of Human Genetics 43(3):A142 (abstract 0566) 1988.

  22. DF Barker, JN Dietz-Band, DE Goldgar, KN Nguyen, AE Turco, CW Donaldson, HF Willard, MH Skolnick, CL Atkin. Mapping of the gene for Alport syndrome (ASLN) within a physically and genetically mapped cluster of X RFLP markers (A2019). Human Gene Mapping 10, Cytogenetics and Cell Genetics 51(1-4):957, 1989.

  23. DF Barker, JN Dietz-Band, DE Goldgar, K Nguyen, AE Turco, CW Donaldson, HF Willard, MH Skolnick, CL Atkin. Mapping the gene for Alport syndrome (ASLN) within a physically and genetically mapped cluster of X RFLP markers. P. 20 in C. Cantor, M. Olson, and R. Roberts editors, Abstracts of papers presented at the April 26-30, 1989, meeting on GENOME MAPPING AND SEQUENCING, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, 1989.

  24. DF Barker, D Goldgar, JN Dietz-Band, K Nguyen, AE Turco, CW Donaldson, HF Willard, MH Skolnick, CL Atkin. Genetic mapping of Alport syndrome (ASLN) with physically and genetically ordered X RFLPs (0671). American Journal of Human Genetics 45 (4 Suppl., Program and Abstracts Volume Fortieth Annual Meeting of the American Society of Human Genetics, Baltimore, Maryland, November 11-15):A172, 1989.

  25. M Gregory, C Atkin, D Goldgar, D Barker, M Skolnick. Allelism of Alport syndrome (AS) types III and IV. American Society of Nephrology Twenty-second Annual Meeting, 12/3-6/89, Washington, DC, p. 60A.

  26. * CL Atkin, A Oliphant, S Wei, BC Cole. Purification of T-cell mitogenic protein from Mycoplasma arthritidis. Ninetieth Annual Meeting of the American Society for Microbiology, May 13-17, 1990, Anaheim, California, abstract G23, p 139.

  27. BC Cole, CL Atkin. The Mycoplasma arthritidis mitogen is a superantigen. Workshop 13/2, Eighth International Congress of the International Organization for Mycoplasmology (IOM), Istanbul, Turkey, July 8-12, 1990. IOM Letters 1:192, 1990.

  28. * DF Barker, AR Oliphant, PR Fain, DE Goldgar, JN Dietz-Band, SC Gerken, AE Turco, MC Gregory, MH Skolnick, CL Atkin, LT Chow, SL Hostikka, J Zhou, K Tryggvason. [Abstract 3.1] Genetic basis for Alport syndrome: disease mapping and identification of COL4A5 mutations. Fifth International Symposium on Basement Membranes, Oulu, Finland, August 8-10, 1990.

  29. J Zhou, SL Hostikka, DF Barker, LT Chow, MC Gregory, CL Atkin, K Tryggvason. [Abstract 3.11] Cloning of the human 5(IV) collagen gene and characterization of mutations in Alport syndrome. Fifth International Symposium on Basement Membranes, Oulu, Finland, August 8-10, 1990.

  30. MC Gregory, D Barker, D Terreros, C Atkin, K Tryggvason. Potential misdiagnosis of female Alport gene-carriers. Journal of the American Society of Nephrology 1:299, 1990.

  31. MC Gregory, J Zhou, D Barker, SL Hostikka, D Wester, A Oliphant, C Atkin, K Tryggvason. Phenotypic heterogeneity resulting from different mutations in the COL4A5 collagen gene in Alport syndrome. Journal of the American Society of Nephrology 1:299, 1990.

  32. J Zhou, SL Hostikka, DF Barker, LT Chow, SC Gerken, CL Atkin, K Tryggvason. Cloning of the 5(IV) collagen gene and characterization of mutations in Alport syndrome (0329). American Journal of Human Genetics 47:A85, 1990.

  33. DF Barker, AR Oliphant, PR Fain, DE Goldgar, JN Dietz-Band, AE Turco, MC Gregory, MH Skolnick, CL Atkin, LT Chow, SL Hostikka, J Zhou, K Tryggvason. Refined genetic and physical mapping of the Alport syndrome locus and identification of mutations in the COL4A5 gene (0812). American Journal of Human Genetics 47:A207, 1990.

  34. DC Wester, CL Atkin, MC Gregory. A clinical study of auditory phenotypes in X-linked Alport syndrome using routine and ultra-high frequency audiometry. Third Annual Convention, American Academy of Audiology, Denver, Colorado. April 25-28, 1991. Audiology Today 3 (2):43, March/April 1991.

  35. DF Barker, PR Fain, DE Goldgar, J Dietz-Band, AE Turco, MH Skolnick, CE Kashtan, MC Gregory, K Tryggvason, CL Atkin. Characterization of markers near and within COL4A5 and their use in studying heterogeneity of Alport syndrome. International Workshop on Alport Syndrome, Oulu, Finland. August 23-24, 1991.

  36. MC Gregory, PN Fain, C Donaldson, DF Barker, CL Atkin. Small-kindred linkage analysis reveals genetic heterogeneity in Alport syndrome (AS). American Society of Nephrology Twenty-fourth Annual Meeting, November 17-20, 1991. Journal of the American Society of Nephrology 2:253, 1991.

  37. MC Gregory, B Skinner, CL Atkin, DF Barker. A novel mutation in COL4A5 relates three families with type IV Alport syndrome. American Society of Nephrology Twenty-fourth Annual Meeting, November 17-20, 1991. Journal of the American Society of Nephrology 2:254, 1991.

  38. MC Gregory, D Terreros, CE Kashtan, L Ptacek, K Tryggvason, DF Barker, CL Atkin. Ultrastructural and immunologic evidence of Alport syndrome (AS) in a kindred with Charcot-Marie-Tooth disease (CMT). American Society of Nephrology Twenty-fifth Annual Meeting, November 17-20, 1991. Journal of the American Society of Nephrology 2:254, 1991.

  39. MC Gregory, D Terreeros, CE Kashtan, CL Atkin, DF Barker. Multiclonal anti-GBM antibodies and Goodpasture syndrome after transplantation in Alport syndrome. American Society of Nephrology Twenty-fifth Annual Meeting, November 15-18, 1992, Washington, DC. Journal of the American Society of Nephrology 3:296 1992.

  40. BC Cole, MM Griffiths, E Ahmed, C Kamerath, CL Atkin. Immunomodulation and autoimmunity induced by the Mycoplasma arthritidis superantigen. In Symposium "Infection Diseases, Their Agents and Superantigens." International Biotechnology Expo & Scientific Conference, San Francisco, October 12-14, 1992.

  41. BC Cole, MM Griffiths, E Ahmed, C Kamerath, CL Atkin. Immunomodulation and autoimmunity induced by the Mycoplasma arthritidis superantigen. Symposium C2, Ninth International Congress of the International Organization for Mycoplasmology (IOM), Ames, Iowa, August 2-7, 1992. IOM Letters 2:17.

  42. MC Gregory, D Terreros, CE Kashtan, CL Atkin, DF Barker. Multiclonal anti-GBM antibodies and Goodpasture syndrome after transplantation in Alport syndrome. American Society of Nephrology Twenty-fifth Annual Meeting, November 15-18, 1992. Journal of the American Society of Nephrology 3:269, 1992.

  43. DF Barker, CL Atkin, MC Gregory, PR Fain. Application of linked markers for genetic diagnosis of Alport syndrome. Second International Workshop on Alport Syndrome, Yale University, New Haven, Connecticut, February 26-27, 1993.

  44. MC Gregory, DF Barker, CE Kashtan, ST Reeders, M Picken, PR Fain, CL Atkin. Autosomal dominant families. Second International Workshop on Alport Syndrome, Yale University, New Haven, Connecticut, February 26-27, 1993.

  45. MC Gregory, CL Atkin, DF Barker, PR Fain. Clinical data collection. Second International Workshop on Alport Syndrome, Yale University, New Haven, Connecticut, February 26-27, 1993.

  46. N Saarinen, J Zhou, A Leinonen, D Barker, M Gregory, C Atkin, K Netzer, M Weber, S Reeders, JM Herz, T Shows, J Springate, C Grönhagen-Riska, K Tryggvason. Identification of 17 small mutations in the COL4A5 gene in Alport syndrome. Journal of the American Society of Nephrology 4:822, 1993.

  47. CL Atkin, A Oliphant, S Wei, A Pole, M Manohar, A Sawitzke, K Knudtson, BC Cole. The Mycoplasma arthritidis superantigen MAM: Purification, sequencing and characterization. Symposium 9-1, Tenth International Congress of the International Organization for Mycoplasmology (IOM). Bordeaux, France, July 19-26, 1994. IOM Letters 3:686, 1994.

  48. N Saarinen, J Zhou, A Leinonen, D Barker, M Gregory, C Atkin, K Netzer, M Weber, S Reeders, JM Herz, T Shows, J Springate, C Grönhagen-Riska, H Neumann, R Trembath, K Tryggvason. Large-scale mutation search on Alport syndrome. Third International Workshop on Alport Syndrome, Erlangen-Nürnberg, Germany, September 11-14, 1994.

  49. * C Atkin. History of Alport Studies in Utah, Fourth International Workshop on Alport Syndrome, Salt Lake City April 15-17, 1999.

VIII. INVITED LECTURES:

Biochemical and clinical studies of hereditary nephritis. ESRD Network #5 Coordinating Council, Denver, Colorado. December 1980.

Genetic heterogeneity of Alport syndrome. Symposium on Hereditary Nephropathy, American Society of Pediatric Nephrology, Washington, DC. May 2, 1988.

Alport syndrome. Fifth International Symposium on Basement Membranes, Oulu, Finland. August 8-10, 1990.

Multiple phenotypes of X-linked and of autosomal dominant nephritides. International Workshop on Alport Syndrome, Oulu, Finland. August 23-24, 1991.

Molecular genetics of Alport syndrome. Symposium "Molecular Genetics in Nephrology," Canadian Society of Nephrology, Québec City, Canada. September 20, 1991.

IX. INTERNET:

CL Atkin. Alport Syndrome Home Page, 1/96 to present.

CL Atkin. Hereditary Nephritis Foundation (HNF) Home Page, 1/96 to present.

CL Atkin. The Alport Forum, message boards and chat, 9/98-present.